Efficacy and Safety of Gadopiclenol for Contrast-Enhanced MRI of the Central Nervous System: The PICTURE Randomized Clinical Trial

Developing new high relaxivity gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) allowing dose reduction while maintaining similar diagnostic efficacy is needed, especially in the context of gadolinium retention in tissues. This study aimed to demonstrate that contrast-en...

Descripción completa

Detalles Bibliográficos
Autores principales: Loevner, Laurie A., Kolumban, Balint, Hutóczki, Gábor, Dziadziuszko, Katarzyna, Bereczki, Daniel, Bago, Attila, Pichiecchio, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090311/
https://www.ncbi.nlm.nih.gov/pubmed/36729404
http://dx.doi.org/10.1097/RLI.0000000000000944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090311/
https://www.ncbi.nlm.nih.gov/pubmed/36729404
http://dx.doi.org/10.1097/RLI.0000000000000944

Ejemplares similares